Tyrosine Kinase


Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
B5953 Dovitinib (TKI258) LactateTarget: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: Oral tyrosine kinase inhibitor (TKI) against FGFR1–3, VEGFR1–3, and platelet-derived growth factor receptor (PDGFR). -
B6006 NPS-1034Summary: MET inhibitor -
B6033 GNF-7Summary: Type II Bcr-Abl inhibitor -
B6054 EAI045Summary: Inhibitor of L858R/T790M EGFR mutants -
B1299 1-NM-PP1Target: Cyclin-Dependent Kinases|Bcr-Abl|Src|Ca2 /calmodulin-dependent protein kinases (CaMKs)|c-FynSummary: Pp60c-src inhibitor -
B1103 Mutant EGFR inhibitorSummary: Selective Mutated EGFR inhibitor -
B1496 IcotinibSummary: EGFR tyrosine kinase inhibitor -
B2301 SAR1316751 CitationSummary: VEGFR3 inhibitor,selective and ATP-competitve -
B2171 Imatinib (STI571)6 CitationTarget: PDGFR|c-Kit|Bcr-AblSummary: Protein-tyrosine kinase inhibitor -
B2302 ZM 323881 HClSummary: selective VEGFR2 inhibitor
